9
Participants
Start Date
July 31, 2013
Primary Completion Date
February 28, 2014
Study Completion Date
February 28, 2015
Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells
Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously.
University of Pittsburgh Medical Center, Pittsburgh
University of California San Francisco Medical Center, San Francisco
Stanford University Medical Center, Stanford
Massachusetts General Hospital, Boston
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Massachusetts General Hospital
OTHER
Stanford University
OTHER
University of Pittsburgh
OTHER
University of Minnesota
OTHER
Michael A. Matthay
OTHER